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Gray Matter Concentration Abnormality
in Brains of Narcolepsy Patients
Objective: To investigate gray matter concentration changes in the brains of
narcoleptic patients. 
Materials and Methods: Twenty-nine narcoleptic patient with cataplexy and 29
age and sex-matched normal subjects (mean age, 31 years old) underwent volu-
metric MRIs. The MRIs were spatially normalized to a standard T1 template and
subdivided into gray matter, white matter, and cerebrospinal fluid (CSF). These
segmented images were then smoothed using a 12-mm full width at half maxi-
mum (FWHM) isotropic Gaussian kernel. An optimized voxel-based morphome-
try protocol was used to analyze brain tissue concentrations using SPM2 (statisti-
cal parametric mapping). A one-way analysis of variance was applied to the con-
centration analysis of gray matter images. 
Results: Narcoleptics with cataplexy showed reduced gray matter concentra-
tion in bilateral thalami, left gyrus rectus, bilateral frontopolar gyri, bilateral short
insular gyri, bilateral superior frontal gyri, and right superior temporal and left infe-
rior temporal gyri compared to normal subjects (uncorrected p < 0.001).
Furthermore, small volume correction revealed gray matter concentration reduc-
tion in bilateral nuclei accumbens, hypothalami, and thalami (false discovery rate
corrected p < 0.05). 
Conclusion: Gray matter concentration reductions were observed in brain
regions related to excessive daytime sleepiness, cognition, attention, and memo-
ry in narcoleptics with cataplexy.
arcolepsy is characterized by excessive daytime sleepiness (EDS), a
disruption of sleep-wake behavior, cataplexy (a sudden loss of muscle
tone provoked by emotional stimuli), and other rapid eye movement
(REM) sleep phenomena, such as, sleep paralysis and hypnagogic hallucinations (1).
Numerous investigations, including neuroimaging studies, have been performed to
characterize the pathophysiology of narcolepsy. An abnormality of the pontine reticu-
lar formation, where REM sleep is generated, was reported in the brain MRIs of three
idiopathic narcoleptic patients (2), whereas another study found no evidence of a
pontine lesion (3).
Several voxel-based morphometry (VBM) studies of brain MRIs in narcoleptics have
produced controversial results. One distinct VBM study revealed reduced gray matter
(GM) concentrations in the hypothalamus and nucleus accumbens (4). A subsequent
study failed to find any changes of GM concentrations in the hypothalamus (5).
Another study found reductions in bilateral inferior temporal and frontal regions (6).
Recently, GM loss in the prefrontal and frontomesial cortices was found, but could not
provide functional significance with respect to the relevance to the pathophysiology of
Eun Yeon Joo, MD
1
Woo Suk Tae, PhD
1, 3
Sung Tae Kim, MD
2










Korean J Radiol 2009;10:552-558
Received March 9, 2009; accepted 
after revision June 8, 2009.
1Department of Neurology, Sleep Center;
2Department of Radiology, Samsung
Medical Center, Sungkyunkwan
University School of Medicine, Seoul 135-
710, Korea; 
3Neuroscience Research
Institute, Kangwon National University
College of Medicine, Kangwon-do 220-
093, Korea
*This study was supported by a Grant
(2009K001257) from Brain Research
Center of the 21st Century Frontier
Research Program funded by the Ministry
of Science, by a grant (no. A090579) of
Good Health R&D Project, Ministry of the
Health & Welfare, Republic of Korea, and
by the Samsung Biomedical Research
Institute grant, #SBRI C-A7-226-3, and by
the Samsung Medical Center Clinical
Research Development Program Grant,
#CRS-108-11-1.
Address reprint requests to:
Seung Bong Hong, MD, Department of
Neurology, Samsung Medical Center,
Sungkyunkwan University School of






Nnarcolepsy due to inhomogeneous patient groups and small
sample size (7).
In the present study, we enrolled narcoleptics with
cataplexy. A VBM analysis was performed on the brain
MRIs of narcoleptic patients and normal subjects to
identify and compare cerebral structural abnormalities in
the narcoleptics with cataplexy.
MATERIALS AND METHODS
Patients 
We consecutively recruited 32 patients with narcolepsy
that visited the university hospital sleep center. The
recruitment criteria included patients with no central
nervous system (CNS) stimulant or cataplexy drug
treatment history. The diagnosis of narcoleptics with
cataplexy was made according to the revised International
Classification of Sleep Disorders. The presence of
cataplexy was determined by criteria outlined by Mignot et
al. (8) and include: 1) loss of muscle tone has a visible
effect or involves other muscle groups in addition to leg
muscles; 2) frequency of cataplexy occurring > 1 per
month; 3) duration of cataplexy (often or always) < 10
min; 4) cataplexy (often or always) associated with normal
state of consciousness. 
A standard polysomnographic study comprising one
overnight recording followed by a MSLT (multiple sleep
latency test) was also performed. MSLT consisted of five
naps scheduled at 2-hour intervals starting at 9:00 AM.
Patients were invited to lie down on a bed in a dark,
sound-attenuated room and instructed to try to fall asleep.
Sleep latency was defined as the time elapsed from the
start of the test (lights out) to the first 30-second epoch
scored as sleep. Each sleep latency test was ended 20
minute after the onset of sleep or after 20 minute of
wakefulness. A sleep onset REM period (SOREMP) was
defined as one or more epochs of REM sleep occurring
within 15 minute of the first 30-second epoch scored as
sleep.
Subjects with a mean sleep latency of ≤ 8 minute on the
MSLT were evaluated for HLA-DQB1*0602 and
DRB1*1501. Other information including the presence of
sleep attacks, hypnagogic hallucinations, sleep paralysis,
and a positive family history of narcolepsy was obtained
from patients and their families. Three of the patients were
excluded because they had concomitant mild to moderate
obstructive sleep apnea hypopnea syndrome. Finally, a
total of 29 narcoleptics with cataplexy were included. 
Normal Subjects
Twenty-nine normal subjects that responded to a local
community advertisement and fulfilled a detailed clinical
interview, sleep questionnaire, overnight polysomnogra-
phy, which were evaluated and interpreted by two sleep
medicine specialists. Exclusion criteria included a normal
subject who showed an apnea-hypopnea index (AHI) > 4 or
evidence for other sleep disorders such as periodic limb
movement disorders on polysomnography. 
The exclusion criteria for normal subjects were those
with a 1) mean daily sleep time < 7 hours, 2) abnormal
sleep-wake rhythm, 3) other sleep disorders, 4) heart or
respiratory disease, 5) history of cerebrovascular disease,
6) other neurological (neurodegenerative diseases,
epilepsy, head injury) or psychiatric diseases (psychosis,
current depression), 7) alcohol or illicit drug abuse or
current intake of psychoactive medications, and 8) a
structural lesion on brain MRI. 
All patients and normal subjects granted written
informed consent before an MRI scan was performed and
the Institutional Review Board at Samsung Medical Center
authorized the informed consent form and study protocol,
which included an MRI scan.
Human Leukocyte Antigen Typing
The human leukocyte antigen (HLA) plays a key role in
autoimmune disease etiology. As one component of the
trimolecular complex (major histocompatibility complex-
peptide-T-cell receptor), the presence of specific HLA
alleles determines the repertoire of peptide epitopes that
can be presented, thereby restricting the specificity of
reactive T cells (9). The HLA class II region genes
DQB1*0602 and DRB1*1501 are currently the best
genetic predictors for narcolepsy in humans (9, 10).
Sequence-specific primers and a BigDye Terminator v.
3.1 cycle Sequencing Kit (Applied Biosystems, Foster City,
CA) were used for HLA-DQB1*0602 and DRB1*1501
genotyping according to manufacturer’s instructions
(Applied Biosystems).
Magnetic Resonance Imaging (MRI)
MRI scanning was performed using a GE Signa 1.5 Tesla
scanner (GE Medical Systems, Milwaukee, WI). T1-
weighted spoiled gradient recalled (SPGR) coronal images
were obtained using the following scanning variables; 1.6
mm thickness, no gap, 124 slices, repetition time/echo time
(TR/TE) = 30/7 msec, flip angle (FA) = 450, number of
excitations (NEX) = 1, matrix = 256 × 192, and field of
view (FOV) = 22 × 22 cm. The investigators performing
the MRI were blinded as to the order of the subject status
was (patients versus normal subjects).
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Image Processing for Voxel-Based Morphometry 
Using SPM2 (Wellcome Department of Cognitive
Neurology, Institute of Neurology, University College
London, UK) and MATLAB 6.5 (The MathWorks, MA), an
optimized VBM protocol was used to analyze brain tissue
concentrations. The brain center point was placed on the
anterior commissure. 
Create Template and Priors
To create customized templates and prior images of GM,
all MRIs of narcoleptic patients and normal controls were
spatially normalized against the standard MNI (Montreal
Neurological Institute) T1 SPM template. Spatial normal-
izations were applied using the following a voxel size of 1
×1×1 mm, cutoff spatial normalization, a 25 mm cutoff’
nonlinear regularization, medium regularization, and 16
nonlinear iterations. The normalized images were
subdivided into GM, white matter (WM), and CSF spaces,
and then sub-sampled for voxel sizes of 2×2 ×2 mm. To
remove the isolated voxels of one tissue class which were
unlikely to be a member of this tissue type, the Hidden
Markov Random Field model was applied in all segmenta-
tion processes. Spatially normalized raw images, as well as
GM and WM were averaged and saved into customized T1
templates, GM, WM, and CSF prior images, respectively.
Finally, the customized T1 template, GM and WM prior
images were smoothed using an 8-mm full-width at half-
maximum (FWHM) isotropic Gaussian kernel (IGK). 
Optimized Voxel-Based Morphometry 
The raw T1 images of all subjects (n = 102) were
automatically subdivided into GM, WM, and CSF
partitions in native space. Spatial normalization parame-
ters were estimated by matching GM with an own GM
template, and then spatially normalized versions of the
original images were created. The spatially normalized
images were segmented using our own images taken
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Table 1. Polysomnographic Findings in Narcoleptics with Cataplexy and Normal Subjects
Narcoleptics with Cataplexy (n = 29) Normal Subjects (n = 29) P
Overnight polysomnography
Mean sleep latency, minute 04.1  5.0 0(0-5.2) 012.8  1.60 (10-15) < 0.001*
Mean REM sleep latency, minute .063.1  45.6 (15-130) 0097.8  17.0 (78-135) < 0.025*
Mean AHI, per hour 03.9  1.5 0(2-7).0 003.7  2.4 0(0-6.1).<   0.468*
Mean arousal index, per hour .0019.2  4.7 0(7.8-24.9) 00017.2  6.9 0(5.2-34.2) < 0.671*
Multiple sleep latency test
Mean sleep latency, minute 0.01.6  2.0 0(0.5-5.0)
Sleep-onset REM sleep periods, number 0.03.4  1.00 (2.0-5.0)
Mean REM sleep latency, minute .003.3  2.50 (0.5-6.8)
Note.─ * Independent t-test, p < 0.05. REM = rapid eye movement, AHI = apnea-hypopnea index




Side x y z
kE Peak Z Uncorrected P
aNucleus accumbens B 0 5 2 429 3.46 0.0002700
aHypothalamus B 9 1 0 0 2.93 0.0020000
aThalamus B 9 -21 4 674 3.75 0.0000880
Gyrus rectus L -73 0 -24 3,260 3.88 0.0000520
Frontopolar gyrus B 0 58 -7 1,053 3.98 0.0000350
Superior frontal gyrus L -13 22 40 463 4.38 0.0000059
R 19 16 61 2,496 3.63 0.0001500
Short insular gyrus L -42 23 -15 643 4.25 0.0000110
R3 2 2 4 -15 491 3.44 0.0003000
Superior temporal gyrus R 40 6 -11 736 3.60 0.0001600
Inferior temporal gyrus L -71 -35 -6 1,057 3.87 0.0000540
Note.─ MNI = Montreal Neurological Institute, B = bilateral, L = left, R = right. Height threshold, uncorrected p < 0.001. Extent threshold kE > 100
a Significant at false discovery rate p < 0.05 by small volume correction using sphere of radius 30 mm located at center point (x, y, z: 0, 0, 0).beforehand (GM, WM, and CSF partitions). The GM
images were smoothed using a 12-mm FWHM IGK and the
final voxel size was 1×1×1 mm.
Statistical Analysis
An ANCOVA covariate with age was used for the
concentration analysis of GM images. The significance
level (height threshold) was set to an uncorrected p value
of < 0.001. In addition, cluster sizes less than 200 voxels
were excluded (extent threshold, kE < 200 voxels). Partial
correlation analyses were set up with confounding factors
such as age between gray matter concentrations (GMCs)
and age of EDS onset, disease duration, mean sleep latency
of MSLT, or Epworth sleepiness scale were performed
using SPM2 using a whole brain mask. 
The mean values of the significant clusters were
extracted from GM images at an uncorrected p-value <
0.001.
Age, EDS or cataplexy onset age, mean ESS (Epworth
sleepiness scale) and SSS (Stanford sleepiness scale), and
night polysomnographic findings were analyzed with the
two-tailed t-test.
To evaluate the prior hypothesis pertaining to the
hypothalamus (4, 11, 12) small volume correction, a
sphere with a radius of 30 mm and located at the center
point (x, y, z: 0, 0, 0), was applied in the results. The
coordinates were defined as per the MNI coordinate
system.
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Fig. 1. Brain regions showing reduced gray matter concentrations in patients with narcolepsy and cataplexy.
A. Overall areas showing reduced gray matter concentrations as whole are shown in glass brain view. 
B. Decreased gray matter concentrations in narcoleptics with cataplexy in: left gyrus rectus, bilateral thalami, bilateral frontopolar gyri,
bilateral short insula gyri, bilateral superior frontal gyri, right superior temporal gyrus, and left inferior temporal gyrus are shown as T1
template overlaid MR image. Uncorrected p < 0.001 (extent threshold kE < 100 voxels). 
C. Bilateral nuclei accumbens (dotted arrows), bilateral hypothalamus (solid arrows), and bilateral thalami (arrowhead) showed reduced
gray matter concentrations at false discovery rate level of corrected p < 0.05 with small volume correction. Superior to inferior panels are
arranged in anterior to posterior direction in coronal images. Left-hand sides of images represent left side of brain. 
A
B CRESULTS
Characteristics of Patients and Normal Subjects
All patients examined were right-handed. The mean age
of the patients and normal subjects (M:F = 15:14) was 31.2
years. The onset age of EDS in patients was 22.3 years
(range of age: 8-37) and the cataplexy was 23.1 years (9-
41). Twenty-three patients (79%) have suffered from
hypnagogic or hypnapompic hallucinations and 19 patients
(65%) had a history of sleep paralysis. The mean Epworth
sleepiness scale result was 17.5 in patients versus 4.3 in
normal subjects (t-test, p < 0.01). Positive HLA typing
(DR2 and DQB1*0602) was identified in 27 (93%) of the
studied patients. The sleep study findings in patients and
normal subjects were summarized in Table 1 (normal
subjects underwent only night polysomnography).
All patients and normal subjects underwent a brain MRI
using the same protocol, which revealed no gross abnormal
findings on visual inspection. 
Voxel-Based Morphometry Analysis
Compared to normal subjects, narcoleptics with
cataplexy showed reduced GM concentrations in bilateral
thalami, left gyrus rectus, bilateral frontopolar gyri,
bilateral superior frontal gyri, bilateral anterior short
insular gyri, right superior temporal gyrus, and left inferior
temporal gyrus at the level of uncorrected p < 0.001 (Fig.
1A, B) (Table 2). There were no regions of the brain that
showed increased GM concentrations in narcoleptics with
cataplexy. Using small volume corrected analysis, the GM
concentration was significantly reduced in bilateral nuclei
accumbens, bilateral hypothalami, and at bilateral thalami
at the level of a false discovery rate p < 0.05 (Fig. 1C). 
A partial correlation analyses with the confounder of age
between GMCs and age of EDS onset, disease duration,
mean sleep latency of MSLT, or Epworth sleepiness scale
did not show statistically significant results.
DISCUSSION
In the present study, a VBM analysis was performed on
the brain MRIs to identify cerebral structural abnormalities
in the narcoleptics with cataplexy. VBM methods for GM
concentrations refer to differences observed in the propor-
tion of GM voxels, which are defined based on signal
intensity thresholds, compared to voxels representing
other tissue types as GM density differences (13). On the
contrary, the thickness of the cerebral cortex (ranging
between 1.5 to 4.5 mm) reflects the density and arrange-
ment of cells (neurons and neuroglia and nerve fibers) (14).
Our study demonstrates a significant decrease in GM
concentrations in the hypothalamus, nucleus accumbens,
thalamus, anterior insular cortex, and in some cortical
areas in the frontal and temporal lobes of the brains of
patients with narcolepsy with cataplexy, when compared
to normal subjects.
In the present study, reduced GM concentrations in the
bilateral hypothalami and nuclei accumbens may be
related to a decreased number of hypocretin immunoreac-
tive neurons in the hypothalamus of a narcoleptic brain
(15). The neuropeptide hypocretin exists exclusively in the
posterior hypothalamus of the human brain and plays a
critical role in the neurobiology of narcolepsy (15). Our
previous FDG-PET (fluorodeoxyglucose-positron emission
tomography) (16) and SPECT (single photon emission
computed tomography) studies (17) showed significant
glucose hypometabolism and hypoperfusion in the bilateral
hypothalami of narcoleptics. A recent proton MR
spectroscopy study revealed that the hypothalamic N-
acetylaspartate-to-creatine ratio was significantly lower in
narcoleptics with cataplexy, when compared to narcolep-
tics without cataplexy or in normal subjects (18). The
nucleus accumbens has been implicated in involvement in
the regulation of the sleep-wake cycle via the mesolimbic-
dopamine system (19), and in the interface between the
limbic and motor systems (20, 21). However, others were
unable to find similar changes in the hypothalamus or
nucleus accumbens (5-7). One study suggested that the
absence of detectable structural changes in hypothalamus
and in hypocretin projection areas may be due to
microscopic changes in these areas that are not detected by
VBM, or alternatively, that functional abnormalities of
hypocretin neurons are not associated with structural
correlates (5). Other VBM studies found that a bilateral
reduction of GM concentrations in inferior temporal and
frontal brain regions (22) or in prefrontal and frontomesial
regions (7). They acknowledged that the functional signifi-
cance of these findings was unclear, but suggested that the
involvement of a presumed autoimmune mediated process
that destroys hypothalamic hypocretin neurons and
extends to other neuronal populations. As pointed out,
inhomogeneous patient groups, a stimulant or antidepres-
sant medication history, and small sample sizes may have
caused the negative findings of previous VBM studies (7).
Because narcolepsy is composed of different subgroups,
i.e., narcoleptics with or without cataplexy, and narcolepsy
with a reduced or a normal hypocretin level in CSF, it is
important that homogenous subgroups of narcoleptic
patients are identified in studies to facilitate accurate inter-
group comparisons. The findings of the present VBM
study, which included reduced GM concentrations in the
Joo et al.
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prior hypothesis that these reductions are associated with
EDS and cataplexy in narcolepsy cases.
Intralaminar nuclei are included in the ‘nonspecific
ascending reticular activating system’ and are functionally
associated with the sense of attention, arousal, and
consciousness (22). These central nuclei are also involved
in the motor function in the basal ganglia circuitry and in
cognitive, oculomotor, and limbic functions (23). The
anterior thalamic nucleus belongs to the Papez circuit, the
neural circuit of emotion. The median thalamic nucleus has
been implicated in the wake-sleep cycle (24). A decrease in
metabolism and regional cerebral blood flow in the
thalamus of the narcoleptic brain, have been demonstrated
by previous neuroimaging studies (16, 17). Thus, the
reduction of GM concentrations in bilateral thalamic nuclei
may be related to attention or cognition deficits, memory
impairments as well as arousal and sleep-wake distur-
bances in narcolepsy. 
Depressive and neurotic symptoms are considered to be
common in narcolepsy (25). Some have suggested that
significant hypoperfusion of the limbic system may be
related to the emotional instability seen in narcoleptics
(17). The insular cortex has numerous connections with the
cerebral cortex, basal ganglia, and limbic structures (26,
27). Mesial temporal lobe epilepsy patients with emotional
symptoms have shown hypometabolism in the anterior
insula by FDG-PET (28, 29). A GMC decrease in the
anterior insular cortex found in narcoleptics with cataplexy
suggested that a structural abnormality in that region may
be associated with the cataplexy induced by emotional
changes. 
We applied two types of statistical analyses, namely, an
unpaired t-test for the group comparisons between the
narcoleptic patients and normal subjects; and a small
volume correction (SVC) on the prior hypothesis, which
mentions the hypothalamus, nucleus accumbens, and
thalamic dysfunction in narcoleptics. The results obtained
by the two methods were similar for the hypothalamus,
nucleus accumbens, and thalamus. The use of SVC in a
SPM analysis is a widely accepted method. A SVC can be
applied when there is prior knowledge or consensus on an
activation effect of a particular region instead of the entire
brain (12, 30). Any clinical or animal experimental data
can be the supportive evidence for a SVC analysis. SPM99
and later versions, use the results to calculate corrected
statistics across the whole brain by working out the shape
and size of the whole brain volume in the analysis, and
calculating the correction accordingly (11). Thus, for a
whole-brain analyses, SPM99 can offer a reasonable
correction factor for the entire brain volume. For smaller
volumes, the correction must take into account the
geometric properties of the volume, such as shape and
surface area. This is important, because you may well have
an a priori hypothesis to test an area of expected activation
in a SPM. Because multiple comparisons across the whole
brain image are too conservative, one must restrict their
region of interest to a subset area instead of using the
whole brain image. Worsley et al. (11) gives results which
allow for the choice of appropriate thresholds given that
you are restricting your investigation to a certain volume
of interest, defined shape, size, and so on. This is because
both size and shape dictate how many resels the volume
will contain. As the random fields tutorial explains, the
number of resels in a volume is a measure related to the
number of independent observations in that volume, and
this in turn will dictate how strict our correction must be
(http://imaging.mrc-cbu.cam.ac.uk/imaging/
SmallVolumeCorrection).
In conclusion, this study revealed significant GM concen-
tration deficits in narcoleptics with cataplexy. Those areas
included structures that may serve possible roles in wake-
sleep controls, attention, or memory. These findings would
be helpful in elucidating the pathomechanism of cerebral
disturbances in patients with narcolepsy with cataplexy.
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